Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Duloxetine Delayed-release NDC 43353-960 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Graphic- 60mg 30s - 43353 0025 30
Duloxetine HCI DR USP is a medication available in 60mg dosage form of 30 capsules. Information on Dioeine FC DR USPSmg. 30 Copsies is not-available.*
Label Graphic- 20mg 3600s - 43353 0106 83
This is a bottle of 3600 capsules containing 20mg of Duloxetine HCI DR USP. The product carries the National Occupational Classification number 3353010680.*
Label Graphic- 30mg 30s - 43353 0960 30
This text is a product label that describes a medicine called "Duloxetine HCI DR USP" which comes in a package of thirty capsules with 30mg strength. It also includes a unique identification number "NOC# 4353098030".*
Aphena Pharma Solutions - TN - Aphena
Figure 1 - duloxetine 02
Figure 2 - duloxetine 03
Figure 3 - duloxetine 04
The text describes a chart showing the percentage of patients who have improved from their pain baseline when taking CYM60/120 mg once daily compared to a placebo. The chart indicates that 100% of patients improved when taking the medication, while no patients improved with the placebo. It also includes a graph displaying the percentage improvement in pain from the baseline.*
Figure 4 - duloxetine 05
This text describes a graph showing the percentage of patients who improved when taking a medication compared to a placebo. The medication is likely called CYMBO and is taken once daily. The graph also shows the percentage of improvement in pain from baseline.*
Figure 5 - duloxetine 06
This document appears to be a graph displaying the percentage of patients improved on placebo versus CYMB0/120 mg once daily, with a percentage range from 0 to 100. Additionally, there is another graph displaying the percentage improvement in pain from baseline using BOCF.*
Chemical Structure - image 01
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.